Emerging nanotechnology backed formulations for the management of atopic dermatitis

Atopic dermatitis is a prevalent chronic skin inflammation affecting 2.1 to 4.1% of adults globally. The complexity of its pathogenesis and the relapsing nature make it challenging to treat. Current treatments follow European Academy of Dermatology and Venerology guidelines, but advanced cases with...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Therapeutic delivery 2023-09, Vol.14 (9), p.543-569
Hauptverfasser:	Mahato, Ranjit Kumar, Singh, Mohini, Pathak, Hemanta, Gogoi, Niva Rani, Kharbithai, Rikynjai, Chowrasia, Pinky, Bora, Pankaj Lochan, Sarkar, Tumpa, Jana, Bani Kumar, Mazumder, Bhaskar
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult atopic dermatitis dermal toxicity Dermatitis, Atopic - drug therapy Dermatitis, Atopic - etiology Dermatitis, Atopic - pathology Drug Delivery Systems drug targeting nanoformulations epidermal disruption Epidermis Humans Inflammation - drug therapy Nanotechnology pruritus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!